The Bone Growth Stimulator Market is set to experience significant growth, according to Emergen Research, with a projected worth of USD 3.80 Billion by 2032. VANCOUVER, Canada - April 20, 2023 — The ...

The global bone growth stimulator market is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. Escalating demand for noninvasive and minimally invasive ...

Bone Growth Stimulator Market Report by TBRC covers the bone growth stimulator market drivers and restraints, size, major players, and the impact of COVID-19 LONDON ...

DUBLIN--(BUSINESS WIRE)--The "Bone Growth Products Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Bone Growth Products Market was valued at USD ...

The US Food and Drug Administration (FDA) on Friday proposed to reclassify non-invasive bone growth stimulators under two product codes from class III to class II, allowing the devices to be marketed ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global Bone Growth Stimulator Market, valued at USD 793 million in 2025, is entering a transformative consolidation phase. According to a new comprehensive ...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. Food and Drug Administration (FDA) ...

Please provide your email address to receive an email when new articles are posted on . Xstim Inc. received FDA premarket application approval of its Xstim spine fusion stimulator. The device is ...

Please provide your email address to receive an email when new articles are posted on . Theragen has announced the issuance of a second U.S. patent for its ActaStim-S, a wearable and app-compatible ...

JACKSONVILLE, Fla., Aug. 18, 2022 /PRNewswire/ -- Medical device company Theragen is pleased to announce the issuance of a U.S. Patent acknowledging its innovative approach to the development of the ...